Structure based on 3kjn |
Ideal structure |
|
| Name: (3s)-3-({[(5s)-2-{2-[(1h-benzimidazol-5-ylcarbonyl)amino]ethyl}-7-(cyclohexylmethyl)-1,3-dioxo-2,3,5,8-tetrahydro-1h-[1,2,4]triazolo[1,2-a]pyridazin-5-yl]carbonyl}amino)-4-oxopentanoic acid |
| Formula: C29 H35 N7 O7 |
| Weight: 593.631 |
| SMILES: "CC(=O)[CH](CC(O)=O)NC(=O)[CH]1C=C(CC2CCCCC2)CN3N1C(=O)N(CCNC(=O)c4ccc5[nH]cnc5c4)C3=O" |
| Spacial conformation based on PDB
3kjn |
RESIDUE B93 78
CONECT C1 4 C2 H1 H1A H1B
CONECT C2 3 C1 O3 C4
CONECT O3 1 C2
CONECT C4 4 C2 C5 N9 H4
CONECT C5 4 C4 C6 H5 H5A
CONECT C6 3 C5 O7 O8
CONECT O7 2 C6 HO7
CONECT O8 1 C6
CONECT N9 3 C4 C10 HN9
CONECT C10 3 N9 O11 C12
CONECT O11 1 C10
CONECT C12 4 C10 C13 N24 H12
CONECT C13 3 C12 C14 H13
CONECT C14 3 C13 C15 C22
CONECT C15 4 C14 C16 H15 H15A
CONECT C16 4 C15 C17 C21 H16
CONECT C17 4 C16 C18 H17 H17A
CONECT C18 4 C17 C19 H18 H18A
CONECT C19 4 C18 C20 H19 H19A
CONECT C20 4 C19 C21 H20 H20A
CONECT C21 4 C16 C20 H21 H21A
CONECT C22 4 C14 N23 H22 H22A
CONECT N23 3 C22 N24 C42
CONECT N24 3 C12 N23 C25
CONECT C25 3 N24 O26 N27
CONECT O26 1 C25
CONECT N27 3 C25 C28 C42
CONECT C28 4 N27 C29 H28 H28A
CONECT C29 4 C28 N30 H29 H29A
CONECT N30 3 C29 C31 HN30
CONECT C31 3 N30 O32 C33
CONECT O32 1 C31
CONECT C33 3 C31 C34 C41
CONECT C34 3 C33 C35 H34
CONECT C35 3 C34 C36 H35
CONECT C36 3 C35 N37 C40
CONECT N37 3 C36 C38 HN37
CONECT C38 3 N37 N39 H38
CONECT N39 2 C38 C40
CONECT C40 3 C36 N39 C41
CONECT C41 3 C33 C40 H41
CONECT C42 3 N23 N27 O43
CONECT O43 1 C42
CONECT H1 1 C1
CONECT H1A 1 C1
CONECT H1B 1 C1
CONECT H4 1 C4
CONECT H5 1 C5
CONECT H5A 1 C5
CONECT HO7 1 O7
CONECT HN9 1 N9
CONECT H12 1 C12
CONECT H13 1 C13
CONECT H15 1 C15
CONECT H15A 1 C15
CONECT H16 1 C16
CONECT H17 1 C17
CONECT H17A 1 C17
CONECT H18 1 C18
CONECT H18A 1 C18
CONECT H19 1 C19
CONECT H19A 1 C19
CONECT H20 1 C20
CONECT H20A 1 C20
CONECT H21 1 C21
CONECT H21A 1 C21
CONECT H22 1 C22
CONECT H22A 1 C22
CONECT H28 1 C28
CONECT H28A 1 C28
CONECT H29 1 C29
CONECT H29A 1 C29
CONECT HN30 1 N30
CONECT H34 1 C34
CONECT H35 1 C35
CONECT H38 1 C38
CONECT H41 1 C41
CONECT HN37 1 N37
END
HET B93 78
HETNAM B93 (3S)-3-({[(5S)-2-{2-[(1H-benzimidazol-5-ylcarbonyl)amin
HETNAM 2 B93 o]ethyl}-7-(cyclohexylmethyl)-1,3-dioxo-2,3,5,8-tetrahy
HETNAM 3 B93 dro-1H-[1,2,4]triazolo[1,2-a]pyridazin-5-yl]carbonyl}am
HETNAM 4 B93 ino)-4-oxopentanoic acid
FORMUL B93 C29 H35 N7 O7
MONOMER page